MedPath

Body Relaxation techniques and Pre-eclampsia Syndrome

Not Applicable
Conditions
Preeclampsia.
Pre-existing secondary hypertension complicating pregnancy, second trimester
O10.412
Registration Number
IRCT20091219002889N11
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
98
Inclusion Criteria

pregnant mothers from 20-24 weeks of gestation,
literacy,
first or second pregnancy,
PES background in previous pregnancy or chronic hypertension in previous pregnancy,
lack of smoking, alcohol and psychotropic substances using history,
high proteinuria up to Trace level, blood pressure less than 140/90 mm Hg,
no psychiatric disorders and severe anxiety (person who scored above 26 on DASS21 questionnaire),
having CD player, a computer or an Android mobile phone in order to listen to the audio of relaxation file at home.
Age range 16 to 43 years

Exclusion Criteria

Stress score obtained from the questionnaire is more than 26
Proteinuria over trace
Blood pressure over than 140/90

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Blood pressure was measured and recorded before and after the intervention in experimental and control group from the beginning and 36 weeks of pregnancy. Method of measurement: Digital Blood Pressure Monitor.;Stress score. Timepoint: stress score was measured and recorded before and after the intervention in experimental and control group from the beginning and 36 weeks of pregnancy. Method of measurement: Dass21 Questionnaire,.;Infant weight. Timepoint: After delivery, birth weight was measured and recorded. Method of measurement: scales.;Gestational age. Timepoint: After delivery, gestational age was measured and recorded. Method of measurement: Gestational age based on LMP or the first sono of pregnancy.;Proteinurine. Timepoint: proteinurine was measured and recorded before and after the intervention in experimental and control group from the beginning and 36 weeks of pregnancy. Method of measurement: Roshe Laboratory Kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath